[Pharmacologic management of dysfunctional uterine hemorrhage]

Non-randomised trial OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-28 ⓘ

This study evaluated hormonal therapy with ethinylestradiol-norethindrone for dysfunctional uterine bleeding, finding an 89.4% success rate in patients under 35 years old.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

From April 1st. to November 15, 1989, 38 patients with disfunctional uterine bleeding, were managed with a combination of ethinylestradiol-norethindrone (0.035 + 0.5mg) for both hemostasis and control. Endometrial sampling with Novak's canula was obtained, and the patient were followed during three months. The mean age was 27 +/- 5.6 years. The mean bleeding time before diagnosis was 12.8 days. The pathologic findings showed a representative distribution of disfunctional disorder. 89.4% of the patients had a good response, with confidence intervals between 81-97%. These findings support hormonal therapy as first alternative in women younger then 35 years old with disfunctional uterine bleeding.

My notes (saved in your browser only)

MeSH descriptors

Uterine Hemorrhage Adolescent Adult Female Humans Uterine Hemorrhage

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:06:23.467768+00:00
License: CC0 · commercial use OK